In this study, we revealed that ATF5 activated by stiff ECMs promoted the proliferation of cancer cells via the transcriptional suppression of EGR1. We showed that ATF5 was activated by stiff ECMs in pancreatic and lung cancer cells. Here, ATF5 is linked to lung carcinoma.